Real-time enrollment status for this inflammatory myopathies clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 7:31 PM UTC
| NCT Number | NCT05895786 |
| Recruiting Status | Recruiting |
| Condition | Inflammatory Myopathies |
| Phase | PHASE3 |
| Target Enrollment | 318 participants |
| Active Locations | 47 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | June 1, 2026 (Jun 1, 2026) |
As of July 17, 2026: Clinical trial NCT05895786 is currently recruiting participants. This phase3 study for inflammatory myopathies is actively seeking new participants at 47 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05895786 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 47 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05895786 was last updated Jun 1, 2026 (June 1, 2026). HelloStudys verifies this status automatically.